Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

NDRA stock hub

ENDRA Life Sciences Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NDRAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

NDRA

In the news

Latest news · NDRA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-291.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-122.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NDRA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

173

Groups with data

Currency

USD

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001681682
Company name	ENDRA Life Sciences Inc.
Country	United States
Country code	US
Cusip	29273B104
Employees	21
Employees Change	0%
Employees Change Percent	0
Enterprise value	$5.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
IPO Date	2017-05-09
Isin	US29273B5003
Last refreshed	2026-05-10
Market cap	$6.1M
Market cap category	Nano-Cap
Price	$4.95
Price currency	USD
Sector	Healthcare
Sic	3845
Symbol	NDRA
Website	https://endrainc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-114.42%
FCF yield	-84.66%
P/B ratio	2.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-7M
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Profit Per Employee	$-334,639
ROA	-86.73
Roa5y	-86.02
ROCE	-185.7
ROE	-291.6
Roe5y	-199.9
ROIC	-122.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-17.65%
Cagr3y	-88.37%
Cagr5y	-85.46%
EPS Growth Years	6
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$3.9M
Cash	$762,365
Current Assets	$967,969
Current Liabilities	$750,956
Debt	$492,352
Debt Equity	$0.22
Equity	$2.3M
Liabilities	$1.6M
Long Term Assets	$2.9M
Long Term Liabilities	$842,721
Net Cash	$270,013
Net Cash By Market Cap	$4.4
Net Cash Growth	-89.79%
Net Debt Equity	$-0.12
Tangible Book Value	$2.3M
Tangible Book Value Per Share	$1.92
WACC	3.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.29
Net Working Capital	$-415,974
Quick ratio	1.02
Working Capital	$217,013

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-289.41%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-17.64%
200-day SMA	4.86
3Y total return	-99.84%
50-day SMA	4.44
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.99%
All Time High	205,800.2
All Time High Change	-100%
All Time High Date	2017-12-26
All Time Low	2.9
All Time Low Change	70.69%
All Time Low Date	2025-05-09
ATR	0.39
Beta	-0.11
Beta1y	2.36
Beta2y	1.05
Ch YTD	9.27
High	5.27
High52	11.96
High52 Date	2025-07-08
High52ch	-58.61%
Low	4.95
Low52	2.9
Low52 Date	2025-05-15
Low52ch	70.69%
Ma50ch	11.49%
Price vs 200-day SMA	1.77%
RSI	51.83
RSI Monthly	31.69
RSI Weekly	45.62
Sharpe ratio	0.52x
Sortino ratio	1.18
Total Return	-289.41%
Tr YTD	9.27
Tr1m	-7.3%
Tr3m	27.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-1.23
Operating Income	$-5.8M
Price target	$30
Price Target Change	$506

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,169,839%
Float Percent	94.28%
Shares Insiders	5.72%
Shares Institutions	6.41%
Shares Out	1,240,751
Shares Qo Q	45.88%
Shares Yo Y	289.41%
Short Float	4.13%
Short Ratio	1.44
Short Shares	3.89

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-5.5M
Average Volume	16,101.3x
Bv Per Share	1.92
CAPEX	$-17,280
Ch1m	-7.3
Ch1y	-17.64
Ch3m	27.25
Ch3y	-99.84
Ch5y	-99.99
Ch6m	-5.26
Change	0%
Change From Open	-3.32
Close	4.95
Days Gap	3.43
Depreciation Amortization	44,045
Dollar Volume	39,555.6
Earnings Date	2026-05-14
Earnings Time	amc
EBIT	$-5.8M
EBITDA	$-5.7M
EPS	$-8.93
F Score	1
FCF	$-5.2M
FCF EV Yield	-88.56x
FCF Per Share	$-4.19
Financing CF	5,732,723
Fiscal Year End	December
Founded	2,007
Investing CF	-3,017,280
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Last Split Date	2024-11-07
Last Split Type	Reverse
Last10k Filing Date	2026-03-31
Ma150	4.88
Ma150ch	1.41%
Ma20	5.1
Ma20ch	-2.98%
Net CF	-2,467,115
Next Earnings Date	2026-05-22
Open	5.12
Optionable	No
Position In Range	0
Post Close	4.95
Postmarket Change Percent	-5.05
Postmarket Price	$4.7
Ppne	504,465
Price Date	2026-05-08
Ptbv Ratio	2.72
Relative Volume	0.5x
Share Based Comp	329,409
Tr6m	-5.26%
Us State	Michigan
Volume	7,991

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NDRA pay a dividend?

Capital-return profile for this ticker.

Performance

NDRA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NDRA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.4%

Float: +94.3% of shares outstanding

Insider ownership

+5.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NDRA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.8

Neutral momentum band

Price vs 200-day MA

+1.8%

50/200-day relationship not available

Beta (5Y)

-0.11

Less volatile than the market

Sharpe ratio

0.52

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NDRA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NDRA stock rating?

ENDRA Life Sciences Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NDRA analysis?

The full report lives at /stocks/NDRA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NDRA?

The latest report frames NDRA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NDRA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.